News

Sareum to provide protein structure determination capabilities to accelerate drug discovery research at Almirall

Using Selerity's Polaratherm, Craft Technologies has conducted experiments to separate retinol and retinyl esters, carotenoids, and tocopherols

The Life Sciences R&D Division of TCS will work on a target protein identified by Congenia as a key protein involved in several age-related diseases.

Cell Signaling Technology, Inc. (CST) has announced an agreement with Novartis under which a pilot study was performed using CST's PhosphoScan™ technology to identify phosphorylation sites and prospective biomarkers of protein kinase targets.

Qiagen has entered into an agreement to acquire key assets of LumiCyte, Inc. (LCI). LC has developed and recently initiated marketing of the products based on its STS- (Surface Tension Segmented) Biochip™ sample preparation solution for MALDI Mass Spectrometry.

Qiagen has entered into a definitive agreement to acquire the assets related to the bioanalytical business of SuNyx GmbH.

P&GP will access a wide range of discovery and preclinical expertise offered by Evotec, ranging from assay development, screening, medicinal and computational chemistry to scale-up and pharmaceutical manufacture.

The department of Biophysical chemistry has successfully deployed Rock Maker and Rock Imager for automation of protein crystallization.

Symyx IntelliChem's electronic lab notebook software enables scientists to replace paper lab notebooks while increasing productivity and data accessibility.

The new version of the HT-12 Series II system has been introduced to provide laboratories with a highly efficient and safe means of routinely removing strongly acidic chemicals from their samples.